Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  General Electric Company    GE

GENERAL ELECTRIC COMPANY (GE)
Mes dernières consult.
Most popular
Report
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

General Electric Company : Omnyx Ships Sixth VL4 Digital Pathology Scanner

share with twitter share with LinkedIn share with facebook
share via e-mail
0
10/27/2011 | 04:05pm CET

GE announced today the shipment of the Omnyx? VL4 scanner to beta customers worldwide. To date, six Omnyx VL4 scanners have been shipped and are in operation for testing purposes. This marks a significant milestone in Omnyx's efforts to deliver a leading Integrated Digital Pathology solution. The Omnyx solution will be demonstrated at the upcoming Pathology Visions conference in San Diego.

The Omnyx VL4 scanner was created through the joint venture of UPMC and GE Healthcare. It is designed to resolve the tradeoff between speed and image quality through its patented two camera technology. All scanning operations including tissue detection and focus are automated to minimize labor. It is tightly integrated to an enterprise software solution that enables high-speed digital viewing over standard networks and provides a complete digital workflow for research use for both the pathologist and histology personnel.

George Michalopolous, Chair of Pathology at UPMC, comments, "The recent shipment of the VL4 Scanner to UPMC allows us to further test the Omnyx technology and make progress with our digitization plans for our department. Whether you look at the software system or their scanning instruments, the Omnyx team has developed an integrated product that promises to advance pathology."

Feedback from the various beta testing sites is instrumental in preparing the products for commercial availability.

Dr. Sylvia Asa, Chair of Pathology at University Health Network said, "I have been impressed with the image quality of the VL4 and I have high expectations for the Omnyx product. The Omnyx images are the best I have seen. In addition, there were several instances when I favored the Omnyx digital image on the monitor over the glass slide in the microscope."

So far, University Health Network (UHN) in Toronto Canada has scanned and reviewed over 2,000 slides as part of its testing activities. The facility started with 5 pathologists and, within 7 weeks, had 22 pathologists from nine specialty areas testing the system. This demonstrates its intuitive ease of use and is a result of the system having been designed by pathologists, for pathologists. Dr. Andrew Evans will discuss UHN's preliminary experience with the Omnyx Integrated Digital Pathology solution and the VL4 scanner at the upcoming Pathology Visions tradeshow in San Diego.

Gene Cartwright, CEO of the Omnyx joint venture comments, "We are grateful and thankful for the support we are receiving from our beta sites. Great customers help us make a better product. There is no better way of making sure we have it right than working hand-in-hand with our customers. We expect the field of digital pathology will advance very quickly once a complete solution is made available. The shipment of the Omnyx VL4 scanner is a very important milestone toward that goal."

The Omnyx Integrated Digital Pathology solution is designed to integrate into a comprehensive platform what are often stand-alone products. It combines high speed, high quality whole slide scanning with scalable information technology products to create a solution that addresses the reliability and process requirements of pathologists and enables single and multi-site organizations to benefit from increased efficiencies and greater access to peers in the field. The Omnyx products are for research use only and not for diagnostic use.

The Omnyx product line will include scanners, workstations, algorithms, servers, and digital archives for storage.

By digitizing the slides and corresponding workflow, the Omnyx solution is intended to do what a traditional microscope cannot, and improve collaboration, communication and efficiency.

ABOUT OMNYX:

Omnyx, LLC, (www.omnyx.com) is a joint venture of GE Healthcare and UPMC (the University of Pittsburgh Medical Center) with locations in Pittsburgh, Pa. and Piscataway, N.J. The company is developing an Integrated Digital Pathology system to allow pathology departments worldwide to move to an all-digital workflow. Their products include a family of high speed whole-slide scanners and an enterprise software product enabling image management, workflow automation, image analysis algorithms and system integration. Close collaboration with pathologists at UPMC and other institutions along with their relationship with GE Healthcare allows Omnyx to focus its innovation on the needs of anatomic pathologists worldwide. Omnyx products are currently in development and are for research use only. They are not for use in diagnostic procedures.

ABOUT GE HEALTHCARE:

GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care. Our broad expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, drug discovery, biopharmaceutical manufacturing technologies, performance improvement and performance solutions services help our customers to deliver better care to more people around the world at a lower cost. In addition, we partner with healthcare leaders, striving to leverage the global policy change necessary to implement a successful shift to sustainable healthcare systems.

Our "healthymagination" vision for the future invites the world to join us on our journey as we continuously develop innovations focused on reducing costs, increasing access and improving quality around the world. Headquartered in the United Kingdom, GE Healthcare is a unit of General Electric Company (NYSE: GE). Worldwide, GE Healthcare employees are committed to serving healthcare professionals and their patients in more than 100 countries. For more information about GE Healthcare, visit our website at www.gehealthcare.com.

For our latest news, please visit http://newsroom.gehealthcare.com

GE Healthcare
Corey Miller, 414.469.5499
[email protected]
OR
Omnyx
Tony Melanson, 857.272.1321
[email protected]


© Business Wire 2011
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on GENERAL ELECTRIC COMPANY
12/15 LOCKHEED MARTIN : to partner with Aerion to develop supersonic business jet
12/15DJU.S. Oil-Rig Count Fell by Four in Latest Week
12/15 BACK TO THE FUTURE : This New Pointy-Nosed Plane Could Make Jet Set Feel Superso..
12/15 GENERAL ELECTRIC : The 5 Coolest Things On Earth This Week
12/15 Exclusive - Safran, Zodiac deal expected to win unconditional EU approval
12/15 EXCLUSIVE : Safran, Zodiac deal expected to win unconditional EU approval - sour..
12/15 GENERAL ELECTRIC : Directors play second fiddle in corporate-governance affairs
12/15 BROTHERS IN ARMS : These Robots Put A New Twist On 3D Printing
12/15 GOVERNOR CUOMO UNVEILS SECOND PROPOS : Protect the Environment, Protect the Huds..
12/15 GENERAL ELECTRIC : A.G. Schneiderman and Gov. Cuomo Announce That NY Will Sue EP..
More news
News from SeekingAlpha
12/15 U.K. regulators OK Hitachi-GE nuclear reactor design
12/15 GENERAL ELECTRIC : A Top Stock Pick For 2018?
12/15 Top Ten Industrial Stocks For Dividend Growth And Income
12/14 Test Portfolio Results And Introducing A New Quality Portfolio
12/13 SALT Repeal Will Upend Fragile Office Markets
Financials ($)
Sales 2017 124 B
EBIT 2017 8 808 M
Net income 2017 7 225 M
Debt 2017 68 291 M
Yield 2017 4,98%
P/E ratio 2017 25,68
P/E ratio 2018 18,96
EV / Sales 2017 1,80x
EV / Sales 2018 1,67x
Capitalization 155 B
Chart GENERAL ELECTRIC COMPANY
Duration : Period :
General Electric Company Technical Analysis Chart | GE | US3696041033 | 4-Traders
Technical analysis trends GENERAL ELECTRIC COMPANY
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 16
Average target price 21,5 $
Spread / Average Target 21%
EPS Revisions
Managers
NameTitle
John L. Flannery Chairman & Chief Executive Officer
Daniel Janki Treasurer & Senior VP-Global Operations
Jamie S. Miller Chief Financial Officer
Jim Fowler Chief Information Officer
Victor Abate Chief Technology Officer & Senior Vice President
Sector and Competitors
1st jan.Capitalization (M$)
GENERAL ELECTRIC COMPANY-43.80%154 537
3M33.90%141 802
HONEYWELL INTERNATIONAL34.48%116 734
SIEMENS-0.51%116 396
ILLINOIS TOOL WORKS INC.33.77%55 724
JARDINE MATHESON HOLDINGS LIMITED12.97%45 246